Delhi High Court · 2026-01-28
CANVA PTY LTD & ORS. vs RXPRISM HEALTH SYSTEMS PRIVATE LIMITED & ANR.
- Citation / case number
- FAO(OS) (COMM)-211/2023 2026:DHC:659-DB
- Court
- Delhi High Court
- Petitioner
- CANVA PTY LTD & ORS.
- Respondent
- RXPRISM HEALTH SYSTEMS PRIVATE LIMITED & ANR.
Judgment text excerpt
$~ * IN THE HIGH COURT OF DELHI AT NEW DELHI Judgment reserved on: 01.12.2025 Judgment pronounced on: 28.01.2026 + FAO(OS) (COMM) 211/2023, CM APPLs. 49322/2023, 49325/2023, 63761/2023 & 63762/2023 CANVA PTY LTD & ORS. .....Appellants Through: Mr. Saikrishna Rajagopal, Ms. Sneha Jain, Dr. Victor Vaibhav Tandon, Ms. Shruti Jain, Mr. Ayush Saxena, Advs. versus RXPRISM HEALTH SYSTEMS PRIVATE LIMITED & ANR. .....Respondents Through: Ms Swathi Sukumar, Sr. Adv. with Mr. Kriti Ranjan, Mr. Vishal, Mr. Ritik Raghuvanshi, Mr. Abhishek Ranjan, Advs. CORAM: HON'BLE MR. JUSTICE C. HARI SHANKAR HON'BLE MR. JUSTICE OM PRAKASH SHUKLA JUDGMENT % 28.01.2026 OM PRAKASH SHUKLA, J. Facilitative Index to the Judgment S. No. Particulars Page Nos. 1. Introduction 2 2. Prelude to the Dispute 5 Signature Not Verified Signed By:ANUBHAV FAO(OS) (COMM) 211/2023 Page 1 of 71 TRIPATHI Signing Date:28.01.2026 19:18:32 3. Proceedings Before the Learned Single 9 Judge 4. Reply to Interim Application 11 5. Impugned Order 14 6. Proceedings Before This Court 20 7. Submission of Appellant 20 8. Submission of Respondent 25 9. Analysis 33 10. Conclusion 68 INTRODUCTION 1. The present appeal is preferred under Section 13(1) of the Commercial Courts Act, 2015, read with Order XLIII Rule 1(r) and Section 151 of the Code of Civil Procedure, 19081, assailing the judgment dated 18.07.2023 passed by the learned Single Judge in I.A. No. 14842/2021 in CS (COMM) 573 of 2021, whereby the application filed by the Respondent/Plaintiff under Order XXXIX Rule 1 & 2 CPC seeking an interim injunction on the ground of alleged infringement of Indian Patent No. 360726 ("Suit Patent") was allowed. 2. For the sake of convenience and consistency, the parties to the present appeal shall be referred to by the same nomenclature as ad